Li‐Sheng Cai

1.1k total citations
27 papers, 510 citations indexed

About

Li‐Sheng Cai is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Li‐Sheng Cai has authored 27 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Gastroenterology and 7 papers in Surgery. Recurrent topics in Li‐Sheng Cai's work include Gastric Cancer Management and Outcomes (12 papers), Metastasis and carcinoma case studies (8 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Li‐Sheng Cai is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Metastasis and carcinoma case studies (8 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Li‐Sheng Cai collaborates with scholars based in China and United States. Li‐Sheng Cai's co-authors include Tianxing Wu, Yongfei Zhu, Xiaodong Zhang, Tianfu Wu, Xudong Ma, Yiqun Huang, Yong Zou, Xiaodong Zhang, Zhenwei Deng and Jianping Lu and has published in prestigious journals such as Nature Communications, Nature Biotechnology and Aquaculture.

In The Last Decade

Li‐Sheng Cai

24 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li‐Sheng Cai China 11 145 116 113 113 80 27 510
Cong Liang China 13 33 0.2× 276 2.4× 26 0.2× 96 0.8× 80 1.0× 36 587
Toru Nakata Japan 16 38 0.3× 357 3.1× 32 0.3× 119 1.1× 71 0.9× 26 774
Xiaoling Zhou China 10 18 0.1× 188 1.6× 29 0.3× 55 0.5× 80 1.0× 25 365
Xiaoshi Ma China 11 18 0.1× 340 2.9× 72 0.6× 73 0.6× 62 0.8× 18 583
Shou‐Feng Zhao China 11 38 0.3× 207 1.8× 50 0.4× 15 0.1× 43 0.5× 18 400
Keun Young Kim South Korea 10 49 0.3× 174 1.5× 32 0.3× 24 0.2× 49 0.6× 30 402
Magdalena Ogłuszka Poland 11 21 0.1× 128 1.1× 48 0.4× 30 0.3× 40 0.5× 30 472
Esin Atık Türkiye 14 55 0.4× 71 0.6× 39 0.3× 46 0.4× 82 1.0× 40 454
Muhammad Ashraf Pakistan 10 82 0.6× 109 0.9× 33 0.3× 138 1.2× 19 0.2× 44 551
Fengjuan Jiang China 13 54 0.4× 215 1.9× 23 0.2× 165 1.5× 22 0.3× 43 521

Countries citing papers authored by Li‐Sheng Cai

Since Specialization
Citations

This map shows the geographic impact of Li‐Sheng Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Sheng Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Sheng Cai more than expected).

Fields of papers citing papers by Li‐Sheng Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Sheng Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Sheng Cai. The network helps show where Li‐Sheng Cai may publish in the future.

Co-authorship network of co-authors of Li‐Sheng Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Sheng Cai. A scholar is included among the top collaborators of Li‐Sheng Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Sheng Cai. Li‐Sheng Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yongbin, Weiming Zeng, Yue Cai, et al.. (2025). Efficacy and safety of sintilimab combined with nab-paclitaxel plus S-1 for neoadjuvant treatment of locally advanced gastric cancer. World Journal of Gastrointestinal Surgery. 17(6). 106361–106361.
4.
Lin, Jian‐Xian, Hua‐Long Zheng, Jianchun Cai, et al.. (2024). Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial. Nature Communications. 15(1). 41–41. 23 indexed citations
5.
Sun, Yuqin, Wei Zhuang, Ran Wei, et al.. (2023). Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer. Journal of Cellular and Molecular Medicine. 27(22). 3578–3590. 7 indexed citations
6.
Sun, Yuqin, Yueqing Chen, Yichen Cai, et al.. (2023). Discovery of CDK signature and CDK5 as potential biomarkers for predicting prognosis and immunotherapeutic response in gastric cancer peritoneal metastases.. PubMed. 13(9). 4087–4100. 2 indexed citations
8.
Lin, Jian‐Xian, Jun-Peng Lin, Jianhua Chen, et al.. (2022). Radiographical Evaluation of Tumor Immunosuppressive Microenvironment and Treatment Outcomes in Gastric Cancer: A Retrospective, Multicohort Study. Annals of Surgical Oncology. 29(8). 5022–5033. 2 indexed citations
9.
Lin, Jian‐Xian, Wei Lin, Fangqin Xue, et al.. (2021). Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer. JAMA Network Open. 4(7). e2116240–e2116240. 31 indexed citations
11.
Chen, Jinping, Guoqiang Su, Guowei Zhang, et al.. (2018). Short-term clinical effects of selecting duodenal transection timing on laparoscopic-assisted distal gastrectomy: a multicentre retrospective study (A report of 239 cases). Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 17(6). 571–580.
12.
Cai, Li‐Sheng, et al.. (2017). MicroRNA‐329 inhibits cell proliferation and tumor growth while facilitates apoptosis via negative regulation of KDM1A in gastric cancer. Journal of Cellular Biochemistry. 119(4). 3338–3351. 16 indexed citations
13.
Yan, Jun, Xiaoling Zheng, Zhangyuanzhu Liu, et al.. (2015). A multicenter study of using carbon nanoparticles to show sentinel lymph nodes in early gastric cancer. Surgical Endoscopy. 30(4). 1294–1300. 36 indexed citations
14.
Li, Wei & Li‐Sheng Cai. (2014). The scope of patent protection for gene technology in China. Nature Biotechnology. 32(10). 1001–1003. 6 indexed citations
15.
Cai, Li‐Sheng, et al.. (2014). Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma. Oncology Reports. 31(6). 2593–2600. 28 indexed citations
16.
Yan, Jun, Fangqin Xue, Hong‐Yuan Chen, et al.. (2014). A multi-center study of using carbon nanoparticles to track lymph node metastasis in T1–2 colorectal cancer. Surgical Endoscopy. 28(12). 3315–3321. 31 indexed citations
17.
Wu, Tianfu, et al.. (2009). Influence of oligosaccharides on the growth and tolerance capacity of lactobacilli to simulated stress environment. Letters in Applied Microbiology. 48(3). 362–367. 59 indexed citations
18.
Zhang, Xiaodong, Tianxing Wu, Li‐Sheng Cai, & Yongfei Zhu. (2007). Influence of fasting on muscle composition and antioxidant defenses of market-size Sparus macrocephalus. Journal of Zhejiang University SCIENCE B. 8(12). 906–911. 16 indexed citations
19.
Zhang, Xiaodong, Tianxing Wu, Li‐Sheng Cai, & Yongfei Zhu. (2007). Effects of α-tocopheryl acetate supplementation in preslaughter diet on antioxidant enzyme activities and fillet quality of commercial-size Sparus macrocephalus. Journal of Zhejiang University SCIENCE B. 8(9). 680–685. 9 indexed citations
20.
Wu, Tianxing, et al.. (2005). Effects of the dietary supplementation with fructooligosaccharides on the excretion of nitrogen and phosphorus inMiichthys miiuyfries. Journal of Zhejiang University SCIENCE A. 6B(8). 798–802. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026